Luofang Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 4

Luofang Bio General Information

Description

Manufacturer of innovative polymer-based pharmaceuticals intended to develop first-in-class therapies for chronic conditions. The company offers AI-driven molecular design, automated synthesis and screening, organ-on-chip validation, and advanced structural analysis, enabling patients with cardiovascular, autoimmune, metabolic, and allergic diseases to access safe and effective long-term treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 2205, Building D2, Nanshan Zhiyuan, Number 1001 Xueyuan Avenue, Changyuan Community
  • Taoyuan Street, Nanshan District
  • Shenzhen, Guangdong
  • China
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Room 2205, Building D2, Nanshan Zhiyuan, Number 1001 Xueyuan Avenue, Changyuan Community
  • Taoyuan Street, Nanshan District
  • Shenzhen, Guangdong
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luofang Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 16-Apr-2026 Completed Startup
To view Luofang Bio’s complete valuation and funding history, request access »

Luofang Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
FountainBridge Capital Venture Capital Minority
Shanghai Xuanqiao Investment Growth/Expansion Minority
Summer Capital (China) Asset Manager Minority
Zhongjun Capital Venture Capital Minority
To view Luofang Bio’s complete investors history, request access »

Luofang Bio FAQs

  • When was Luofang Bio founded?

    Luofang Bio was founded in 2025.

  • Where is Luofang Bio headquartered?

    Luofang Bio is headquartered in Shenzhen, China.

  • What industry is Luofang Bio in?

    Luofang Bio’s primary industry is Drug Discovery.

  • Is Luofang Bio a private or public company?

    Luofang Bio is a Private company.

  • What is Luofang Bio’s current revenue?

    The current revenue for Luofang Bio is .

  • Who are Luofang Bio’s investors?

    FountainBridge Capital, Shanghai Xuanqiao Investment, Summer Capital (China), and Zhongjun Capital have invested in Luofang Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process